Vernon Mitchell May, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 |
Suresh Saxena, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 |
Taunya M Jasper, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 |
David Hargrove Parker, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 |
Jennifer Ann Spath, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 |
Bradley Coleman Chase, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 |
Janice Marie Kregor, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 |
Robert Allan Blair, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 |
Dr. Dana Lynn Gibson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 202 Limestone St S Ste 1a, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 |
Amael Abdel Shalash, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 |
News Archive
Madison Dearborn Partners announced today that it has signed a definitive agreement under which it will acquire a majority ownership position in Ikaria, Inc., a leading provider of proprietary and innovative therapies for the critical care units in hospitals.
Results from a small study suggest that consumption of an elemental diet for 2–4 weeks results in a significant histologic improvement in adult patients with eosinophilic esophagitis.
This time of year parents in northern regions bundle up their children in preparation for winter activities. In addition to layers of warm clothing, gloves, and boots, parents often use whatever athletic headgear is available to mitigate the potential hazards of winter sports and play.
Researchers in the United States have predicted the binding epitopes of uncharacterized neutralizing antibodies that target the receptor-binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
ChemoCentryx, Inc., today announced the initiation of a Phase II clinical trial for CCX168, an orally-administered small molecule for the treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a disease which can lead to renal and pulmonary failure.
› Verified 4 days ago